VAL077
Demirci C|Özkahya M|Demirci M|Hür E|Momin Adam S|Ok E|Başçi A|Töz H
BANTAO Journal 2009; Volume 7: Supplement 1, OP-06
OBJECTIVE: We investigated whether the amount of extracellular water (ECW) assessed by bioimpedance analysis (BIA) predicts mortality in hemodialysis (HD) patients.
SUBJECTS/METHODS: In June 2006, ECW was measured by multifrequency BIA (Bodystat Quadscan 4000, British Isles) on a midweek interdialytic day and was corrected for body surface area (BSA) in 502 maintenance HD patients (mean age 55.9 ±13.5 yrs, HD duration 54 ±42 mo, female 41%, diabetes 35.8%). Demographical, clinical and laboratory data were recorded at the time of analysis. Overall and cardiovascular (CV) mortality were assessed during a mean follow-up of 22 ±17 months (1 to 36 ).
RESULTS: Ninety-three deaths were observed during follow-up, 53 from CV diseases. ECW-BSA was significantly lower in survivors compared to non-survivors (9.63± 0.73 vs 9.90± 0.83 L/m, respectively; p=0.004). In multivariate Cox regression analysis, after adjusting for all variables, ECW-BSA was an independent predictor of both overall and CV mortality (RR: 1.48, p=0.007 and RR: 1.80, p=0.002; respectively) (table). Patients with ECW-BSA below 9.62 L/m2 (median value) had a significantly better 3-year cumulative survival than patients with a ECW-BSA equal or higher than 9.62 L/m2 (p=0.01) (figure).
CONCLUSION: High extracellular fluid volume is an independent predictor of both cardiovascular and overall mortality in HD patients.
Download Paper – Extracellular Fluid Volume and Mortality in Hemodialysis
Extracellular Fluid Volume and Mortality in Hemodialysis.
SUBSCRIBE TO OUR NEWSLETTER
Stay up to date with all the latest news and research from Bodystat